TCM
CURE icon

Traynor Capital Management’s Direxion Daily Healthcare Bull 3X ETF CURE Stock Holding History

Traynor Capital Management’s Portfolio CURE Stock Details CURE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$531K Sell
4,737
-475
-9% -$44.7K 0.02% 189
2026
Q1 		$452K Sell
5,212
-10
-0.2% -$1.08K 0.03% 187
2025
Q4 		$583K Sell
5,222
-541
-9% -$55.3K 0.03% 171
2025
Q3 		$481K Sell
5,763
-404
-7% -$31.5K 0.03% 188
2025
Q2 		$507K Sell
6,167
-3,918
-39% -$317K 0.04% 136
2025
Q1 		$1.08M Sell
10,085
-150
-1% -$16K 0.09% 85
2024
Q4 		$945K Sell
10,235
-488
-5% -$55K 0.06% 105
2024
Q3 		$1.43M Sell
10,723
-76
-0.7% -$9.78K 0.09% 89
2024
Q2 		$1.26M Buy
10,799
+100
+0.9% +$11.3K 0.09% 86
2024
Q1 		$1.34M Sell
10,699
-107
-1% -$12.4K 0.12% 86
2023
Q4 		$1.1M Buy
10,806
+786
+8% +$70.4K 0.11% 87
2023
Q3 		$887K Buy
10,020
+1,697
+20% +$167K 0.11% 91
2023
Q2 		$832K Buy
8,323
+1,246
+18% +$124K 0.1% 91
2023
Q1 		$679K Buy
7,077
+1,590
+29% +$160K 0.1% 104
2022
Q4 		$630K Buy
5,487
+84
+2% +$9.09K 0.09% 112
2022
Q3 		$456K Sell
5,403
-527
-9% -$54.4K 0.08% 101
2022
Q2 		$611K Sell
5,930
-1,805
-23% -$203K 0.11% 84
2022
Q1 		$1.01M Sell
7,735
-254
-3% -$30.2K 0.13% 78
2021
Q4 		$1.16M Sell
7,989
-269
-3% -$32.7K 0.14% 80
2021
Q3 		$887K Sell
8,258
-226
-3% -$27.2K 0.12% 91
2021
Q2 		$935K Sell
8,484
-115
-1% -$11K 0.13% 81
2021
Q1 		$718K Buy
8,599
+461
+6% +$37.2K 0.12% 88
2020
Q4 		$626K Sell
8,138
-5,758
-41% -$396K 0.11% 84
2020
Q3 		$928K Buy
13,896
+1,232
+10% +$77.3K 0.21% 62
2020
Q2 		$688K Buy
12,664
+3,284
+35% +$174K 0.17% 72
2020
Q1 		$373K Buy
9,380
+3,358
+56% +$212K 0.13% 85
2019
Q4 		$443K Sell
6,022
-154
-2% -$9.41K 0.12% 104
2019
Q3 		$312K Sell
6,176
-232
-4% -$12.3K 0.1% 119
2019
Q2 		$365K Buy
6,408
+218
+4% +$11.2K 0.12% 107
2019
Q1 		$344K Sell
6,190
-69
-1% -$3.67K 0.12% 109
2018
Q4 		$297K Sell
6,259
-1,137
-15% -$63.9K 0.12% 109
2018
Q3 		$492K Sell
7,396
-85
-1% -$4.86K 0.16% 90
2018
Q2 		$341K Buy
7,481
+1,422
+23% +$63.6K 0.12% 116
2018
Q1 		$260K Sell
6,059
-21,626
-78% -$1.09M 0.11% 132
2017
Q4 		$1.29M Sell
27,685
-333
-1% -$15.4K 0.55% 39
2017
Q3 		$1.25M Sell
28,018
-1,377
-5% -$59.4K 0.6% 39
2017
Q2 		$1.23M Buy
29,395
+7,695
+35% +$285K 0.61% 35
2017
Q1 		$911K Buy
21,700
+14,180
+189% +$461K 0.51% 42
2016
Q4 		$210K Buy
+7,520
New +$212K 0.14% 109

Other funds holding CURE

SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
OBWG
Onyx Bridge Wealth Group Tarrytown, New York $1.11B AUM 24.65% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Traynor Capital Management's CURE Position: Q2 2026 in Review

Traynor Capital Management reduced its Direxion Daily Healthcare Bull 3X ETF (CURE) stake by 9.1% in Q2 2026, selling an estimated $44.7K and leaving 4,737 shares worth $531K. The position accounts for 0.02% of the portfolio, ranked #189.

Traynor Capital Management first reported a position in CURE in Q4 2016 and has held it in 39 quarters since. The position peaked at $1.43M in Q3 2024. 4 funds tracked by Wall St. Rank hold CURE as of Q2 2026.

  • Traynor Capital Management held 4,737 shares of Direxion Daily Healthcare Bull 3X ETF worth $531K as of Q2 2026.
  • Traynor Capital Management sold 475 Direxion Daily Healthcare Bull 3X ETF shares in Q2 2026, an estimated $44.7K.
  • Direxion Daily Healthcare Bull 3X ETF made up 0.02% of Traynor Capital Management's portfolio in Q2 2026, its #189 holding.
  • Traynor Capital Management first reported a position in Direxion Daily Healthcare Bull 3X ETF in Q4 2016 and has held it in 39 quarters since.
  • Traynor Capital Management's Direxion Daily Healthcare Bull 3X ETF position peaked at $1.43M in Q3 2024.
  • 4 funds tracked by Wall St. Rank held Direxion Daily Healthcare Bull 3X ETF as of Q2 2026.

Based on Traynor Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.